1.2M
Downloads
942
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
7 days ago
7 days ago
In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles:
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289)
Speakers:
Brad Rovin, MD
Richard Furie, MD
Jack Cush, MD
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.